AU2003276488A1 - High purity ondansetron hydrochloride dihydrate and process for its synthesis - Google Patents

High purity ondansetron hydrochloride dihydrate and process for its synthesis

Info

Publication number
AU2003276488A1
AU2003276488A1 AU2003276488A AU2003276488A AU2003276488A1 AU 2003276488 A1 AU2003276488 A1 AU 2003276488A1 AU 2003276488 A AU2003276488 A AU 2003276488A AU 2003276488 A AU2003276488 A AU 2003276488A AU 2003276488 A1 AU2003276488 A1 AU 2003276488A1
Authority
AU
Australia
Prior art keywords
synthesis
high purity
hydrochloride dihydrate
ondansetron hydrochloride
ondansetron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003276488A
Inventor
Laszlo Czibula
Ida Deutschne Juhasz
Laszlo Dobay
Istvan Hegedus
Judit Nagyne Bagdy
Ruben Olah
Laszlo Terdy
Geza Toth
Tamasne Uberhardt
Eva Werkne Papp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of AU2003276488A1 publication Critical patent/AU2003276488A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
AU2003276488A 2002-10-17 2003-10-16 High purity ondansetron hydrochloride dihydrate and process for its synthesis Abandoned AU2003276488A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HUP0203547 2002-10-17
HU0203547A HU225885B1 (en) 2002-10-17 2002-10-17 Process for producing ondansetron hydrochlorid dihydrate of high purity
PCT/HU2003/000081 WO2004035567A1 (en) 2002-10-17 2003-10-16 High purity ondansetron hydrochloride dihydrate and process for its synthesis

Publications (1)

Publication Number Publication Date
AU2003276488A1 true AU2003276488A1 (en) 2004-05-04

Family

ID=89980861

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003276488A Abandoned AU2003276488A1 (en) 2002-10-17 2003-10-16 High purity ondansetron hydrochloride dihydrate and process for its synthesis

Country Status (3)

Country Link
AU (1) AU2003276488A1 (en)
HU (1) HU225885B1 (en)
WO (1) WO2004035567A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2565854A1 (en) 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
ZA200305338B (en) * 2001-01-11 2004-07-12 Teva Pharma An improved process for preparing pure ondansetron hydrochloride dihydrate.

Also Published As

Publication number Publication date
HU225885B1 (en) 2007-11-28
HUP0203547A3 (en) 2004-10-28
HU0203547D0 (en) 2002-12-28
HUP0203547A2 (en) 2004-06-28
WO2004035567A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
AU2003238980A1 (en) Process for obtaining of bulk monocrystallline gallium-containing nitride
IL196010A0 (en) Pyrazole derivatives and process for the production thereof
AU2003264400A1 (en) Process for producing arylamine
AU2003278355A1 (en) Process
SG115596A1 (en) Process for preparing tert-butanol
SI1403264T1 (en) Process for the industrial synthesis of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxydimethylester
AU2003218704A1 (en) Process for preparing 2-aminoindan derivatives
AU2003211279A1 (en) Process for producing proanthocyanidine-rich material
AU2003263622A8 (en) Process for preparing prostaglandin derivatives and starting materials for the same
EP1547993A4 (en) Process for preparation of spirofluorenols
AU2003250151A1 (en) Method for the synthesis of anthracycline-peptide conjugates
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
AU2002367890A1 (en) Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
AU2003287174A1 (en) Process for synthesizing antifolates
AU2003263586A1 (en) A process for the synthesis of bisbenzimidazoles and its derivations
AU2003261766A1 (en) Process for production of 4-alkylphenols
AU2003241100A1 (en) Process for preparing high purity azithromycin
AU2003276488A1 (en) High purity ondansetron hydrochloride dihydrate and process for its synthesis
AU2003292820A1 (en) 4-amino-5-methylpyrazole derivatives and process for production thereof
AU2003224327A1 (en) Process for the synthesis of peptides
AU2002330736A1 (en) An improved process for the synthesis of pharmacologically active (z/e)-guggulsterones
AU2003263197A1 (en) Process
AU2003254791A1 (en) Process for production of amides
AU2003235129A1 (en) Process for preparation of 2-aminoketones
AU2003295132A1 (en) Process for production of deoxygalactonojirimycin derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase